{
  "items": [
    {
      "title": "Johnson & Johnson (JNJ) Ranked 4th Best S&P 500 Dividend Aristocrat According to Hedge Funds",
      "description": "We recently published a list of S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Sentiment. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other S&P 500 dividend aristocrats sorted by hedge fund sentiment. Dividend Aristocrats are companies that have consistently increased their dividend payments […]",
      "published_utc": "2025-02-25T22:43:47",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=8c534c0835c136112dc2b59598a3522e576b92a60d389c1584884859a4ec0dc4",
      "category": "company",
      "image": "https://s.yimg.com/ny/api/res/1.2/DBFyZ0OZ_JyFkP8R8eQoiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/f9ccf3c88c7274582ef19e20143427c2",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 132902104,
      "datetime": 1740494627
    },
    {
      "title": "J&J’s potential neurovascular exit: implications for market dynamics",
      "description": "The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.",
      "published_utc": "2025-02-25T19:38:56",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=3a2b3db73f08d02fb1f17a999c21bb091a5230c03a844a6ddac2e6218a1fe0ea",
      "category": "company",
      "image": "https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2025/02/shutterstock_2008564148.jpg",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 132902105,
      "datetime": 1740483536
    }
  ]
}